NFE2L2 and breast carcinoma: Notably, overexpression of CD44 has been shown to increase the levels of Nrf2 in human breast cancer stem-cell-like cells; the Nrf2 levels were further increased by HA treatment, whereas CD44 depletion had the opposite effect [35].